{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T03:12:57Z","timestamp":1775531577147,"version":"3.50.1"},"reference-count":29,"publisher":"e-Century Publishing Corporation","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ospa2864","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:57:12Z","timestamp":1761728232000},"page":"7789-7802","source":"Crossref","is-referenced-by-count":2,"title":["Predictive value of beta amyloid, phosphorylated Tau, neurofilament light chain, and glial fibrillary acidic protein for depression in Alzheimer's disease"],"prefix":"10.62347","volume":"17","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer’s disease","volume":"397","author":"Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J and van der Flier WM. Alzheimer’s disease. Lancet 2021; 397: 1577-1590.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3233\/JAD-220938","article-title":"Impact of hearing aids on progression of cognitive decline, depression, and quality of life among people with cognitive impairment and dementia","volume":"92","author":"RZ","year":"2023","unstructured":"Atef RZ, Michalowsky B, Raedke A, Platen M, Mohr W, Mühlichen F, Thyrian JR and Hoffmann W. Impact of hearing aids on progression of cognitive decline, depression, and quality of life among people with cognitive impairment and dementia. J Alzheimers Dis 2023; 92: 629-638.","journal-title":"J Alzheimers Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archpsyc.61.6.587","article-title":"The nature and determinants of neuropsychological functioning in late-life depression","volume":"61","author":"Butters","year":"2004","unstructured":"Butters MA, Whyte EM, Nebes RD, Begley AE, Dew MA, Mulsant BH, Zmuda MD, Bhalla R, Meltzer CC, Pollock BG, Reynolds CF 3rd and Becker JT. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 2004; 61: 587-595.","journal-title":"Arch Gen Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer’s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R and Hansson O. Tau biomarkers in Alzheimer’s disease: towards implementation in clinical practice and trials. Lancet Neurol 2022; 21: 726-734.","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G and Imbimbo BP. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease. Nat Rev Neurol 2019; 15: 73-88.","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamapsychiatry.2016.3162","article-title":"Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis","volume":"74","author":"Ismail","year":"2017","unstructured":"Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, Mortby ME, Smith EE, Patten SB and Fiest KM. Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry 2017; 74: 58-67.","journal-title":"JAMA Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archneurol.2010.297","article-title":"Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease","volume":"67","author":"Reitz","year":"2010","unstructured":"Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R and Luchsinger JA. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol 2010; 67: 1491-1497.","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nec.2024.11.008","article-title":"Diagnostic and prognostic biomarkers of idiopathic normal pressure hydrocephalus in cerebrospinal fluid and blood","volume":"36","author":"Kamalian","year":"2025","unstructured":"Kamalian A, Masoudi M, Foroughmand I and Moghekar A. Diagnostic and prognostic biomarkers of idiopathic normal pressure hydrocephalus in cerebrospinal fluid and blood. Neurosurg Clin N Am 2025; 36: 207-231.","journal-title":"Neurosurg Clin N Am"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer’s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","unstructured":"Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JP, Teich AF, Airey DC, Proctor NK, Dage JL and Mayeux R. Plasma p-tau181, p-tau217, and other blood-based Alzheimer’s disease biomarkers in a multi-ethnic, community study. Alzheimers Dement 2021; 17: 1353-1364.","journal-title":"Alzheimers Dement"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease","volume":"11","author":"Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM and Martins RN. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease. Transl Psychiatry 2021; 11: 27.","journal-title":"Transl Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"10012","DOI":"10.3390\/ijms251810012","article-title":"Association of MicroRNA expression and serum neurofilament light chain levels with clinical and radiological findings in multiple sclerosis","volume":"25","author":"Dom&#xED","year":"2024","unstructured":"Domínguez-Mozo MI, Casanova I, Monreal E, Costa-Frossard L, Sainz-de-la-Maza S, Sainz-Amo R, Aladro-Benito Y, Lopez-Ruiz P, De-Torres L, Abellán S, Garcia-Martinez MA, De-la-Cuesta D, Lourido D, Torrado-Carvajal A, Gomez-Barbosa C, Linares-Villavicencio C, Villar LM, López-De-Silanes C, Arroyo R and Alvarez-Lafuente R. Association of MicroRNA expression and serum neurofilament light chain levels with clinical and radiological findings in multiple sclerosis. Int J Mol Sci 2024; 25: 10012.","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer’s disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B and Reddy DH. Neuroinflammation in Alzheimer’s disease: current progress in molecular signaling and therapeutics. Inflammation 2023; 46: 1-17.","journal-title":"Inflammation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9768","DOI":"10.1038\/s41598-025-94632-8","article-title":"Intratracheal Candida administration induced lung dysbiosis, activated neutrophils, and worsened lung hemorrhage in pristane-induced lupus mice","volume":"15","author":"Bhunyakarnjanarat","year":"2025","unstructured":"Bhunyakarnjanarat T, Udompornpitak K, Wannigama DL, Ruchusatsawat A, Aphiboon P, Sripong T, Thim-Uam A and Leelahavanichkul A. Intratracheal Candida administration induced lung dysbiosis, activated neutrophils, and worsened lung hemorrhage in pristane-induced lupus mice. Sci Rep 2025; 15: 9768.","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Morisaki M, Rezaali F, Lau LC, Boche D, Khandaker GM, Turecki G and Sinclair LI. Depression as a risk factor for Alzheimer’s disease: a human post-mortem study. PLoS One 2025; 20: e0320561.","DOI":"10.1371\/journal.pone.0320561"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"112715","DOI":"10.1016\/j.bbr.2020.112715","article-title":"High IL-6 in military personnel relates to multiple traumatic brain injuries and post-traumatic stress disorder","volume":"392","author":"Rodney","year":"2020","unstructured":"Rodney T, Taylor P, Dunbar K, Perrin N, Lai C, Roy M and Gill J. High IL-6 in military personnel relates to multiple traumatic brain injuries and post-traumatic stress disorder. Behav Brain Res 2020; 392: 112715.","journal-title":"Behav Brain Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease","volume":"7","author":"McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S and Phelps CH. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 263-269.","journal-title":"Alzheimers Dement"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"749649","DOI":"10.3389\/fnagi.2021.749649","article-title":"Performance of plasma amyloid β, total tau, and neurofilament light chain in the identification of probable Alzheimer’s disease in South China","volume":"13","author":"Jiao","year":"2021","unstructured":"Jiao B, Liu H, Guo L, Liao X, Zhou Y, Weng L, Xiao X, Zhou L, Wang X, Jiang Y, Yang Q, Zhu Y, Zhou L, Zhang W, Wang J, Yan X, Tang B and Shen L. Performance of plasma amyloid β, total tau, and neurofilament light chain in the identification of probable Alzheimer’s disease in South China. Front Aging Neurosci 2021; 13: 749649.","journal-title":"Front Aging Neurosci"},{"key":"ref17","unstructured":"Zhang LF, Zhang YP, Lin PX and Xue LH. Efficacy and safety of sodium oligomannate in the treatment of Alzheimer’s disease. Pak J Pharm Sci 2022; 35: 741-745."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in subjective cognitive decline and mild cognitive impairment","volume":"269","author":"Giacomucci","year":"2022","unstructured":"Giacomucci G, Mazzeo S, Bagnoli S, Ingannato A, Leccese D, Berti V, Padiglioni S, Galdo G, Ferrari C, Sorbi S, Bessi V and Nacmias B. Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in subjective cognitive decline and mild cognitive impairment. J Neurol 2022; 269: 4270-4280.","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders - towards clinical application","volume":"20","author":"Khalil","year":"2024","unstructured":"Khalil M, Teunissen CE, Lehmann S, Otto M, Piehl F, Ziemssen T, Bittner S, Sormani MP, Gattringer T, Abu-Rumeileh S, Thebault S, Abdelhak A, Green A, Benkert P, Kappos L, Comabella M, Tumani H, Freedman MS, Petzold A, Blennow K, Zetterberg H, Leppert D and Kuhle J. Neurofilaments as biomarkers in neurological disorders - towards clinical application. Nat Rev Neurol 2024; 20: 269-287.","journal-title":"Nat Rev Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2022.02.008","article-title":"Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice","volume":"102","author":"Lama","year":"2022","unstructured":"Lama A, Pirozzi C, Severi I, Morgese MG, Senzacqua M, Annunziata C, Comella F, Del Piano F, Schiavone S, Petrosino S, Mollica MP, Diano S, Trabace L, Calignano A, Giordano A, Mattace Raso G and Meli R. Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice. Brain Behav Immun 2022; 102: 110-123.","journal-title":"Brain Behav Immun"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer’s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer’s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J 2023; 290: 1420-1453.","journal-title":"FEBS J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1038\/s41598-021-85183-9","article-title":"HDL biodistribution and brain receptors in zebrafish, using HDLs as vectors for targeting endothelial cells and neural progenitors","volume":"11","author":"Sulliman","year":"2021","unstructured":"Sulliman NC, Ghaddar B, Gence L, Patche J, Rastegar S, Meilhac O and Diotel N. HDL biodistribution and brain receptors in zebrafish, using HDLs as vectors for targeting endothelial cells and neural progenitors. Sci Rep 2021; 11: 6439.","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1186\/s12967-024-05905-1","article-title":"Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice","volume":"22","author":"Li","year":"2024","unstructured":"Li X, Wang K, Sun Y, Wang Y, Wu J, Dang Y, Li M and Zhou W. Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice. J Transl Med 2024; 22: 1085.","journal-title":"J Transl Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease","volume":"19","author":"Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease. J Neuroinflammation 2022; 19: 206.","journal-title":"J Neuroinflammation"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3390\/v15091898","article-title":"The association of HHV-6 and the TNF-α (-308G\/A) promotor with major depressive disorder patients and healthy controls in Thailand","volume":"15","author":"Sumala","year":"2023","unstructured":"Sumala S, Ekalaksananan T, Pientong C, Buddhisa S, Passorn S, Duangjit S, Janyakhantikul S, Suktus A and Bumrungthai S. The association of HHV-6 and the TNF-α (-308G\/A) promotor with major depressive disorder patients and healthy controls in Thailand. Viruses 2023; 15: 1898.","journal-title":"Viruses"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Li S, Zhang Y, Wang Y, Zhang Z, Xin C, Wang Y and Rong P. Transcutaneous vagus nerve stimulation modulates depression-like phenotype induced by high-fat diet via P2X7R\/NLRP3\/IL-1β in the prefrontal cortex. CNS Neurosci Ther 2024; 30: e14755.","DOI":"10.1111\/cns.14755"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Janelidze S, Palmqvist S, Cullen N, Svenningsson AL, Strandberg O, Mengel D, Walsh DM, Stomrud E, Dage JL and Hansson O. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease. Brain 2020; 143: 3234-3241.","journal-title":"Brain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H and Blennow K; Alzheimer’s Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 2017; 74: 557-566.","journal-title":"JAMA Neurol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0167542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:42:03Z","timestamp":1769132523000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/10\/ajtr0167542.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/ospa2864","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}